Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-05-023535
Filing Date
2005-05-03
Accepted
2005-05-03 16:46:22
Documents
2
Period of Report
2005-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1564
2 POA DOCUMENT poa.txt EX-24.3_83605 1375
  Complete submission text file 0001209191-05-023535.txt   4903
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address C/O NORTEL NETWORKS 8200 DIXIE ROAD STE 100 BRAMPTON ONTARIO A6 L6T 5P6 9058631160
STEVENSON KATHARINE BERGHUIS (Reporting) CIK: 0001232227 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-15190 | Film No.: 05795676